Clinical Hematology/Oncology Fellow, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Research Associate, Department of Psychology, St. Jude Children's Research Hospital, Memphis, TN.
CA Cancer J Clin. 2018 Mar;68(2):133-152. doi: 10.3322/caac.21445. Epub 2018 Jan 29.
The population of adult survivors of childhood cancer continues to grow as survival rates improve. Although it is well established that these survivors experience various complications and comorbidities related to their malignancy and treatment, this risk is modified by many factors that are not directly linked to their cancer history. Research evaluating the influence of patient-specific demographic and genetic factors, premorbid and comorbid conditions, health behaviors, and aging has identified additional risk factors that influence cancer treatment-related toxicity and possible targets for intervention in this population. Furthermore, although current long-term follow-up guidelines comprehensively address specific therapy-related risks and provide screening recommendations, the risk profile of the population continues to evolve with ongoing modification of treatment strategies and the emergence of novel therapeutics. To address the multifactorial modifiers of cancer treatment-related health risk and evolving treatment approaches, a patient-centered and risk-adapted approach to care that often requires a multidisciplinary team approach, including medical and behavioral providers, is necessary for this population. CA Cancer J Clin 2018;68:133-152. © 2018 American Cancer Society.
随着生存率的提高,儿童癌症成年幸存者的人数不断增加。尽管已经明确这些幸存者会经历与恶性肿瘤及其治疗相关的各种并发症和合并症,但这种风险受到许多与癌症病史并无直接关联的因素的影响。研究评估了患者特定的人口统计学和遗传因素、发病前和合并症情况、健康行为以及衰老对癌症治疗相关毒性的影响,并确定了其他影响因素,这些因素可能成为该人群干预的目标。此外,尽管目前的长期随访指南全面涵盖了特定的治疗相关风险,并提供了筛查建议,但随着治疗策略的不断调整以及新型疗法的出现,该人群的风险状况仍在不断演变。为了应对癌症治疗相关健康风险的多因素修饰因子以及不断发展的治疗方法,需要针对该人群采用以患者为中心且适应风险的治疗方法,这种方法通常需要多学科团队的参与,包括医疗和行为提供者。CA Cancer J Clin 2018;68:133-152. © 2018 American Cancer Society.